I&I startup Attovia Therapeutics files for IPO as biotech listing wave gains pace

Attovia Therapeutics, an I&I startup that develops biologics, filed a registration statement to go public on Tuesday after the market closed.

The filing brings the number of biotech companies expected to list in the next few weeks to three, indicating a growing pipeline of offerings.

Industry observers see the increase in pending IPOs as a sign of renewed investor appetite for biotech assets, which could boost capital availability for companies in the sector.